Another study demonstrated that the surface molecule signaling lymphocytic activation molecule family member 4 (SLAMF4; CD244) is pivotal for the cytotoxic activity of CD8+ T-cells assessed by CD107a in SLE-patients (19). Here, CD8A is linked to systemic lupus erythematosus.